HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Radiotherapy, Chemotherapy Claims Draw FDA “Courtesy” Letter

This article was originally published in The Tan Sheet

Executive Summary

Colin Worldwide is in compliance with FDA regulations after deleting certain claims for its Paecilomyces hepiali chen & Ganoderma nutritional supplement, the agency says in a June 3 letter

You may also be interested in...



“Dry Throat” Not A Disease, “Soothe” A Cosmetic Claim, Tom’s Of Maine Says

Tom's of Maine may not claim its eponymous Natural Bronchial Syrup for Children and Natural Bronchial Syrup for Adults "sooth[es] dry throat," FDA says in a recent "courtesy" letter

Earthmends Breast, Prostate Health Formula Claims Under FDA Review

The Cancer Wellness Institute's line of Earthmends Breast Health and Prostate Health dietary supplements will continue to carry claims they provide nutritional support for individuals undergoing cancer treatment or trying to prevent cancer, the Palm Harbor, Fla.-based company said.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS130842

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel